Company Performance Metrics
Focal develops, manufactures and commercializes synthetic, absorbable, liquid surgical sealants based on the Company's proprietary polymer technology. The Company's family of FOCALSEAL surgical sealant products is currently being developed for use inside the body with or without sutures and staples to seal leaks resulting from lung,
neuro, cardiovascular and gastrointestinal surgery. FOCALSEAL-L, the Company's first surgical sealant product, will initially be used to seal air leaks following lung surgery. The Company has entered into an
exclusive marketing and distribution agreement for its surgical sealant products outside North America with Ethicon, a worldwide leader in surgical wound closure products. The Company anticipates commercial launch of FOCALSEAL-L for lung surgery indications in Europe through Ethicon in the first half of 1998.
